HALO
Halozyme Therape (HALO)
NASDAQ
$113.00+$0.55 (+0.49%)
Price as of Sep 18, 2026 7:56 PM EDT
  • $12.8B
    Market Cap
  • 44.52%
    1-Year Change
  • Biotechnology
    Industry
HALO
vs History
vs S&P 500
General Statistics
Latest Close
$112.45
Change
+$2.77 (+2.53%)
Open
$109.72
High
$112.66
Low
$109.38
Previous Close
$109.68
Volume
10,348,962
30-Day Average Volume
1,923,845
1-Week Change
4.90%
1-Month Change
7.21%
1-Year Change
44.52%
3-Year Change
187.52%
5-Year Change
167.48%
Fundamentals
Shares Outstanding
113.5M
Total Assets
$2.6B
Market Cap
$12.8B
Enterprise Value
$14.7B
Period:
QTR
TTM
FY
Revenue
$307.7M
Net Income
$229.9M
Free Cash Flow
$236.7M
EBIT
$285.3M
EBITDA
$314.8M
Net Working Capital
$588.6M
EPS
$1.90
Enterprise Value/EBITDA
47
Enterprise Value/Revenue
48
P/B
89
P/E
59
PEG
1
Price/Free Cash Flow
54
Price/Operating Cash Flow
53
Dividends & Splits
Forward Annual Dividend Yield
N/A
Trailing Annual Dividend Yield
N/A
Ex-Dividend Date
N/A
Last Split Factor
N/A
Last Split Date
N/A

Earnings & Revenue